23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition
...
PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting
...
Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making
...
Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse
...
M&A Report: Roche Merges with GenMark Diagnostics to Create Syndromic Testing Powerhouse
...